Monitor for any future conversion to Schedule 13D or additional stake increases, which could signal activist intent. As a passive filing, no immediate catalyst is expected.
Price Chart
Executive Summary
Coastlands Capital LP and related entities filed a Schedule 13G disclosing a 6.41% passive stake in Frazier Life Sciences Acquisition Corp. II, a blank-check company. The filing indicates no intent to influence control, consistent with a routine investment in a SPAC.
Key Financial Metrics
Key Facts
- Coastlands Capital LP and affiliates beneficially own 500,000 Class A Ordinary Shares of Frazier Life Sciences Acquisition Corp. II.
- The stake represents 6.41% of the 7,800,000 Class A Ordinary Shares outstanding as of October 15, 2026.
- The filing is a Schedule 13G, indicating passive investment intent with no control-seeking purpose.
- The securities are held directly by Coastlands Capital Partners LP; the other reporting persons disclaim beneficial ownership except for pecuniary interest.
Financial Impact
Passive 6.41% stake in a SPAC; no financial impact disclosed.
Risk Factors
- Potential future conversion to activist stance if the investor files a Schedule 13D.
- SPAC de-SPAC risk: the target merger may underperform or fail to close.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-116496 |
| Document: 0001104659-26-116496-index-headers.html | 0001104659-26-116496 |
| Document: 0001104659-26-116496-index.html | 0001104659-26-116496 |
| Document: 0001104659-26-116496.txt | 0001104659-26-116496 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G | $10.21 | awaiting T+5 | — | $10.23 (+0.20%) |
Oct 22, 2026 5d ago | 8-K | $10.30 | awaiting T+5 | — | $10.23 (−0.68%) |
Oct 22, 2026 5d ago | SC 13G | $10.30 | awaiting T+5 | — | $10.23 (−0.68%) |
Oct 21, 2026 6d ago | SC 13D | $10.27 | awaiting T+5 | — | $10.23 (−0.39%) |
Oct 21, 2026 6d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.23 (−0.39%) |
Oct 21, 2026 6d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.23 (−0.39%) |
Oct 16, 2026 11d ago | SC 13G | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.23 (−1.16%) |
Oct 15, 2026 12d ago | Insider Buy | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.23 (−1.16%) |
Oct 15, 2026 12d ago | 8-K | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.23 (−1.16%) |
Oct 14, 2026 13d ago | 424B4 | $10.49 $10.27 | ▼ −2.10% | ▼ −1.08% | $10.23 (−2.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers